The Ketamine Advocacy Network was founded at the National Institutes of Health in 2012 by ketamine clinical trial volunteers. They personally experienced the power ketamine has to rapidly relieve the excruciating pain of refractory depression.
The founders quickly learned how difficult it is to get ongoing ketamine therapy from local doctors at affordable rates. And they encountered firsthand the powerful forces preventing widespread adoption of the treatment. The Ketamine Advocacy Network was born from their desire to overcome these obstacles and share the relief they experienced with fellow sufferers.
Since 2012, our ranks have grown to include alumnae from other clinical studies, patients of ketamine clinics, doctors and administrators who run those clinics, and concerned loved ones. We all share the same desire to spread awareness and acceptance of this powerful new weapon against depression, bipolar, and PTSD.